Cargando…
Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models
The tumor vasculature differs from normal blood vessels in morphology, composition and stability. Here, we describe a novel tumor vessel-disrupting mechanism. In an HT1080/mouse xenograft tumor model rhodocetin-αβ was highly effective in disrupting the tumor endothelial barrier. Mechanistically, rho...
Autores principales: | Niland, Stephan, Komljenovic, Dorde, Macas, Jadranka, Bracht, Thilo, Bäuerle, Tobias, Liebner, Stefan, Eble, Johannes A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976474/ https://www.ncbi.nlm.nih.gov/pubmed/29854288 http://dx.doi.org/10.18632/oncotarget.25032 |
Ejemplares similares
-
Neuropilins in the Context of Tumor Vasculature
por: Niland, Stephan, et al.
Publicado: (2019) -
Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively
por: Eble, Johannes A., et al.
Publicado: (2017) -
Correction: Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively
por: Eble, Johannes A., et al.
Publicado: (2017) -
TNP-470 Suppresses the Tumorigenicity of HT1080 Fibrosarcoma Tumor
Through the Inhibition of VEGF Secretion From the Tumor Cells
por: Kaya, Mitsunori, et al.
Publicado: (2001) -
Characterization of cachexia in the human fibrosarcoma HT‐1080 mouse tumour model
por: Bernardo, Barbara, et al.
Publicado: (2020)